Literature DB >> 12604030

The crossflow injection technique: an improvement of the ethanol injection method.

Andreas Wagner1, Karola Vorauer-Uhl, Günther Kreismayr, Hermann Katinger.   

Abstract

A novel scalable liposome preparation technique for pharmaceutical application is presented. Previous experiments have shown that the concept of continuous crossflow injection is a promising approach. For the characterization of the process, we focus on the influencing parameters like the lipid concentration, the injection hole diameter, the injection pressure, the buffer flow rate, and system performance. These experiments demonstrate that the injection hole diameter and the system performance do not influence the vesicle forming process and that a minimum of buffer flow rate is required to affect batch homogeneity. In contrast, strongly influencing parameters are lipid concentration in combination with increasing injection pressures. After exceeding the upper pressure limit of the linear range, where injection velocities remain constant, the vesicle batches are narrowly distributed, also when injecting higher lipid concentrations. Reproducibility and scalability data show similar results with respect to vesicle size and size distribution and demonstrate the stability and robustness of the novel continuous liposome preparation technique.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12604030     DOI: 10.1081/lpr-120014761

Source DB:  PubMed          Journal:  J Liposome Res        ISSN: 0898-2104            Impact factor:   3.648


  9 in total

1.  Liposome Formation Using a Coaxial Turbulent Jet in Co-Flow.

Authors:  Antonio P Costa; Xiaoming Xu; Mansoor A Khan; Diane J Burgess
Journal:  Pharm Res       Date:  2015-10-01       Impact factor: 4.200

2.  Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms.

Authors:  Abhay U Andar; Renee R Hood; Wyatt N Vreeland; Don L Devoe; Peter W Swaan
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

3.  Liposome technology for industrial purposes.

Authors:  Andreas Wagner; Karola Vorauer-Uhl
Journal:  J Drug Deliv       Date:  2010-12-05

4.  Conjugation of Native-Like HIV-1 Envelope Trimers onto Liposomes Using EDC/Sulfo-NHS Chemistry: Requirements and Limitations.

Authors:  Ehsan Suleiman; Julia Mayer; Elisabeth Lehner; Bianca Kohlhauser; Alexandra Katholnig; Mirjam Batzoni; Dominik Damm; Vladimir Temchura; Andreas Wagner; Klaus Überla; Karola Vorauer-Uhl
Journal:  Pharmaceutics       Date:  2020-10-16       Impact factor: 6.525

Review 5.  Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue.

Authors:  Roxana-Maria Amarandi; Alina Ibanescu; Eugen Carasevici; Luminita Marin; Brindusa Dragoi
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

Review 6.  A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.

Authors:  Peng Liu; Guiliang Chen; Jingchen Zhang
Journal:  Molecules       Date:  2022-02-17       Impact factor: 4.411

7.  Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.

Authors:  Wendi V Rodrigueza; Michael J Woolliscroft; Abdul-Shukkur Ebrahim; Robert Forgey; Patrick J McGovren; Gerold Endert; Andreas Wagner; Danielle Holewa; Amro Aboukameel; Richard D Gill; Charles L Bisgaier; Richard A Messmann; Christopher E Whitehead; Elzbieta Izbicka; Robert Streeper; Michael C Wick; Gabriela Stiegler; C A Stein; David Monsma; Craig Webb; Mina P Sooch; Steffen Panzner; Ramzi Mohammad; Neal C Goodwin; Ayad Al-Katib
Journal:  Cancer Chemother Pharmacol       Date:  2014-05-16       Impact factor: 3.333

8.  Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics.

Authors:  Carla B Roces; Gustavo Lou; Nikita Jain; Suraj Abraham; Anitha Thomas; Gavin W Halbert; Yvonne Perrie
Journal:  Pharmaceutics       Date:  2020-11-15       Impact factor: 6.321

Review 9.  mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles.

Authors:  Andreas Ouranidis; Theofanis Vavilis; Evdokia Mandala; Christina Davidopoulou; Eleni Stamoula; Catherine K Markopoulou; Anna Karagianni; Kyriakos Kachrimanis
Journal:  Biomedicines       Date:  2021-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.